Settlement was reached to resolve allegations that an Ohio based long-term care pharmacy, solicited and received kickbacks from drug manufacturer in return for implements “therapeutic interchange” programs that were designed to switch Medicaid beneficiaries from a competitor drug to the product Aranesp.

Kickbacks took the form of performance-based rebates that were tied to market-share or volume thresholds, as well as grants, speaker fees, consulting services, data fees, dinners and travel.

“The District of South Carolina has devoted significant resources over the last three years pursuing claims under the False Claims Act, and this settlement is the latest example of this office’s successful efforts. I am very proud of the work this office has done in this area.” – Bill Nettles

Case Results